← BackCV Sciences, Inc. · DrugmakersCVSI
High riskNext report: Around Nov 12 (est.)
The short versionA company still losing money with shrinking sales, with elevated risk.
Watch out for
- Share count growing 10.1% a year (dilution)
- Losing money
- Debt above equity: 1.12x
Money moves
- No insider buying or selling in the last 30 days
Facts from SEC filings, not a recommendation.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$3.0M-18% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $12.7M, down 15% from the 12 months before. Over 5 years, sales shrank about 11% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-58.7%
- MissDebt under half of equityNot relying on borrowed money.1.12x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-6.9%
- MissProfitable every yearSteady profits, not one good year.2 of 10 years
- MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$516K
- MissShare count not growingNot diluting owners. Falling means buybacks.+33.5% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.49.0%
- Revenue
- $13.8M
- -12.2% vs prior year
- 5-year growth
- -10.8%/yr
- revenue, per year
- Total debt
- $1.6M
- 1.12x equity
- Current ratio
- 1.03x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $3.0M
- -17.5% YoY
- EPS
- $0.00
- vs $0.00
- Op. margin
- -10.1%
- -6.5 pts
- Gross margin
- 48.6%
- -2.3 pts
- Free cash flow
- $13K
- Share count
- +11.3%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
67/ 100
- This week
- 1
- Normal week
- 0.5
- vs normal
- 2.0x
SEC filings of any kind. 50 means a normal week.
Share count growthYearly rate, last 3 years
+13.4%Cash runwayAt last year's cash burn
8 monthsDebt to equityLatest balance sheet: debt compared with what owners have
0.0x · $18K debtShares outstandingLatest reported
226MWhy high risk- Losing money
- About 8 months of cash left at its current burn
- Share count growing 13.4% a year (dilution)
- Bills due within a year exceed short-term assets
- Revenue down 12.2% from the year before
Next reportAround Nov 12 (est.)Estimated from the same quarter last year
- Results filedAug 13
- Results filedMay 14
- Results filedMar 26
- Results filedNov 13, 2025
- Results filedAug 13, 2025
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.